Back to all studiesRecruitingNCT06793488
Anxiety During Abstinence in AUD
Official study titleNeural Mechanisms of Anxiety During Early and Protracted Abstinence in Alcohol Use Disorder
Medication studyAges 21–55United StatesAddiction
The study in practiceUnderstand this study
Who could participate?
Listed age limits: 21 years to 55 years.
- Activities
- Medication described in the protocol · Study assessments
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarifyThis summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarityThings to check before joining
Study start dateStarted: September 15, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Columbia University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- DIAGNOSTIC_TEST, Medication / drug
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT06793488
Want help reviewing this study?
Study ID: NCT06793488. We help you review the study, but cannot decide medical eligibility.
A listed location does not confirm current availability.
FAQQuestions about this study
Who is behind this study?
The study sponsor is Columbia University, a university.
Does this study involve medication?
Yes. The study involves medication, including Disulfiram 250 mg.
Who can participate?
Listed age limits: 21 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Explore other studiesWant to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me